Cargando…
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study
Many drugs have been tried for the treatment/prevention of COVID-19 with limited success. Direct household contacts of COVID-19 patients are at highest risk for SARS-CoV-2 infection. Hydroxychloroquine (HCQ) has been tried against COVID-19 owing to its in vitro virucidal action against SARS-CoV-2, b...
Autores principales: | Dhibar, Deba Prasad, Arora, Navneet, Kakkar, Arpit, Singla, Neeraj, Mohindra, Ritin, Suri, Vikas, Bhalla, Ashish, Sharma, Navneet, Singh, Mini P., Prakash, Ajay, PVM, Lakshmi, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646370/ https://www.ncbi.nlm.nih.gov/pubmed/33166694 http://dx.doi.org/10.1016/j.ijantimicag.2020.106224 |
Ejemplares similares
-
The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality
por: Dhibar, Deba Prasad, et al.
Publicado: (2023) -
Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19
por: Singla, Neeraj, et al.
Publicado: (2021) -
COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India
por: Mohindra, Ritin, et al.
Publicado: (2021) -
Clinical, Biochemical Characteristics and Hospital Outcome of Acute Intermittent Porphyria Patients: A Descriptive Study from North India
por: Kumar, Susheel, et al.
Publicado: (2017) -
Prognostic significance of poison-related factors and consumption patterns in acute aluminum phosphide poisoning
por: Anbalagan, Lokhesh Chockalingam, et al.
Publicado: (2023)